Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) fell 2.4% during trading on Friday . The stock traded as low as GBX 100 ($1.24) and last traded at GBX 102.50 ($1.27). 42,693 shares traded hands during mid-day trading, an increase of 2% from the average session volume of 41,958 shares. The stock had previously closed at GBX 105 ($1.30).
Celadon Pharmaceuticals Trading Down 2.4 %
The company has a debt-to-equity ratio of 153.26, a quick ratio of 6.97 and a current ratio of 1.86. The company has a 50-day simple moving average of GBX 99.32 and a 200 day simple moving average of GBX 101.60. The company has a market capitalization of £65.82 million and a P/E ratio of -788.46.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- With Risk Tolerance, One Size Does Not Fit All
- 3 Stocks Leading the U.S. Agriculture Comeback
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Stock Market Upgrades: What Are They?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
